Fazarabine: A report of response in a patient with multiply relapsed embryonal cell carcinoma

P. G. Johnston, D. Kleiner, K. H. Cowan

Research output: Contribution to journalArticle

2 Scopus citations


This report describes a patient with multiply relapsed and advanced metastatic embryonal cell carcinoma who achieved a pathological partial remission (PR) following treatment with a Phase I chemotherapeutic agent, arabinosyl-5-azacytosine (Ara-AC), followed by orchiectomy. The antimetabolic Ara-AC is worthy of further study in patients with germ-cell tumors. It would appear that the antimetabolite Ara-AC may have significant activity in patients with germ-cell tumors.

Original languageEnglish (US)
Pages (from-to)34-37
Number of pages4
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number1
Publication statusPublished - Jan 1 1993


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this